🇺🇸 FDA
Patent

US 7084159

Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases

granted A61PA61P1/00A61P1/04

Quick answer

US patent 7084159 (Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases) held by Vertex Pharmaceuticals Incorporated expires Mon Jul 27 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Aug 01 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 27 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61P, A61P1/00, A61P1/04, A61P1/16, A61P1/18